Green Thumb Industries (GTII) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
25 Feb, 2026Executive summary
Fourth quarter 2025 revenue reached $311.1 million, up 5.7% year-over-year, with full-year revenue at $1.18 billion, a 3.4% increase over 2024.
Net income for Q4 was $83.2 million ($0.36 per basic share), and for the year $114.2 million ($0.49 per basic share), driven by favorable fair value adjustments on related party warrants.
Retail footprint expanded by 12 stores to 113 locations across 14 states, with significant contributions from Minnesota's transition to adult-use sales.
Strong cash position at year-end ($274.3 million) and increased credit facility by $50 million post-quarter.
Financial highlights
Q4 gross profit was $141.3 million (45.4% margin), down from $158.1 million (53.7%) year-over-year due to price compression.
Full-year gross profit was $574.9 million (48.9% margin), down from $601.1 million (52.9%) in 2024.
Normalized EBITDA for Q4 was $100.2 million (32.2% of revenue); for the year, $348.4 million (29.6% of revenue).
Cash flow from operations was $90.0 million in Q4 and $294.9 million for the year.
Repurchased 7.7 million Subordinate Voting Shares for $38.9 million in 2025; cumulative buybacks since September 2023 total 15.5 million shares for $121.8 million.
Outlook and guidance
Q1 2026 revenues expected to decline sequentially by mid-single digits due to ongoing pricing pressure and seasonality.
2026 capital expenditures anticipated at approximately $80 million, similar to 2025.
Latest events from Green Thumb Industries
- Market leader in THC with strong brands, financials, and growth from regulatory tailwinds.GTII
Investor presentation - Q2 revenue up 5% to $307M, strong cash flow, and robust share buybacks amid regulatory progress.GTII
Q2 2026 - All proposals passed, with strong financials and strategic focus on regulatory and brand growth.GTII
AGM 2026 - Cannabis market growth and brand leadership drive strong financial results and national expansion.GTII
Investor presentation - Cannabis market growth and brand leadership drive robust revenue and EBITDA performance.GTII
Investor presentation - Q1 2026 revenue up 7.5% to $300.2M, strong cash flow, and expanded share buybacks.GTII
Q1 2026 - Q2 revenue up 4.7% to $293.3M, but margins pressured by price compression and regulatory headwinds.GTII
Q2 2025 - Q3 revenue up 4% to $287M, Adjusted EBITDA margin 31.1%, strong cash flow and liquidity.GTII
Q3 2024 - Revenue up 1.4% to $280M, but net income and margins declined amid price compression.GTII
Q1 2025